HeartFlow, Inc.
Updated: 15 Jun 2026
No signal published yet
We already track HeartFlow and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.
Email when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Temporary check — not Firelda's published signal.
General analysis — not personal advice.
Want to follow HeartFlow, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow HeartFlow free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Recent News
In April 2023, the company secured $215 million in a Series F funding round led by Bain Capital Life Sciences to support the commercialization of its product suite. Throughout 2024 and 2025, the company has focused on integrating its FDA-cleared plaque analysis software into clinical workflows and expanding its HeartFlow ONE platform.
What Firelda Watch includes for HeartFlow, Inc.
Add the company to your watchlist and get all of this automatically.
- Free: 3 companies on your watchlist
- Change history and monitoring for every company you follow
- Sunday weekly brief — a short weekly roundup
- Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
Want to follow HeartFlow, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow HeartFlow free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more